Form 4: Conmed Corp Director LaVerne H. Council Reports Stock Transactions
SEC Form 4
Director LaVerne H. Council reports acquisition and disposal of Conmed Corp stock and derivative securities.
Summary
- On May 31, 2024, Director LaVerne H. Council exercised restricted stock units (RSUs) converting 302 units into common stock.
- Following this transaction, Council directly owns 3,569 shares of Conmed Corp common stock.
- On June 3, 2024, Council was granted 5,503 options to purchase common stock at a price of $77.18, which vest 100% after one year and expire on June 3, 2034.
- Council was also granted 479 restricted stock units (RSUs) on June 3, 2024, which vest 100% after one year and expire on June 3, 2034.
- Council has granted power of attorney to Heather L. Cohen, Lindsey F. Brewer, and Thomas Fistek to handle SEC filings on their behalf.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The grant of stock options and RSUs to a director aligns their interests with those of the shareholders.
- The vesting period of one year for both the stock options and RSUs encourages long-term commitment from the director.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates changes in the holdings of a company director, which is common practice.
Comparison to Industry Standards
- Stock option and RSU grants are common compensation practices for directors in publicly traded companies like Conmed Corp.
- Vesting schedules of one year are typical for such grants, aligning with industry standards for incentivizing long-term performance.
- Companies like Medtronic, Johnson & Johnson, and Stryker also utilize similar equity-based compensation for their directors.
Stakeholder Impact
- The transactions reported may be of interest to shareholders as they provide insight into the director's holdings and alignment with company performance.
- The grant of stock options and RSUs can incentivize the director to act in the best interests of the company and its shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023-09-13 | Date of execution of the Limited Power of Attorney. |
| 2024-05-31 | Date of RSU exercise and conversion to common stock. |
| 2024-06-03 | Date of grant of stock options and RSUs. |
| 2025-06-03 | Vesting date for stock options and RSUs granted on June 3, 2024. |
| 2033-06-01 | Expiration date for RSUs granted on May 31, 2024. |
| 2034-06-03 | Expiration date for stock options and RSUs granted on June 3, 2024. |
| 2024-06-04 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.